Coya Therapeutics (COYA)
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cel...
- Open
- 4.820
- High
- 4.820
- Low
- 4.550
- Prev. Close
- 4.860
- Volume
- 153.11K
- Turnover
- 709.88K
- Avg Price
- 4.636
- Bid/Ask Ratio
- --
- Amplitude
- 5.56%
- 52wk High
- 7.750
- Volume Ratio
- 0.77
- Turnover Ratio
- 0.86%
Coya Therapeutics Analyst Rating
View moreForecast & Rating
Aug 24, 2026Price forecast
$15.21231.47%
Forecast & RatingStrong buy
7analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Aug 23 at 05:35 PM
Roth MKM Sticks to Its Buy Rating for Coya Therapeutics, Inc. (COYA)
- Market Beat · Aug 11 at 10:11 AM
Coya Therapeutics (NASDAQ:COYA) Posts Earnings Results, Beats Estimates By $0.08 EPS
- PUBT · Aug 11 at 07:20 AM
Coya Therapeutics posts investor presentation on Treg-directed combination therapy for neurodegenerative diseases
- PUBT · Aug 7 at 04:03 PM
Coya Therapeutics amends filing to name Mark Pavao to audit committee
- Market Beat · Jul 24 at 01:40 AM
Coya Therapeutics (NASDAQ:COYA) Trading Up 0.2% - Should You Buy?
- Tip Ranks · Jul 6 at 01:05 AM
Roth MKM Reaffirms Their Buy Rating on Coya Therapeutics, Inc. (COYA)
